HORMONE-REFRACTORY METASTATIC PROSTATIC-CANCER TREATED WITH METHOTREXATE, CYCLOPHOSPHAMIDE PLUS ADRIAMYCIN, CIS-PLATINUM PLUS 5-FLUOROURACIL PLUS CYCLOPHOSPHAMIDE - NATIONAL PROSTATIC-CANCER PROJECT RANDOMIZED TRIAL

被引：22
作者：
MURPHY, GP
PRIORE, RL
SCARDINO, PT
机构：
[1] BAYLOR COLL MED,DEPT UROL,HOUSTON,TX 77030
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
UROLOGY | 1988年 / 32卷 / 01期
关键词：
D O I：
10.1016/0090-4295(88)90450-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 40
页数：8
相关论文
共 26 条
[21]   IS THERE EVIDENCE THAT CHEMOTHERAPY IS OF BENEFIT TO PATIENTS WITH CARCINOMA OF THE PROSTATE [J].
TANNOCK, IF .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) :1013-1021
[22]   THE CHEMOTHERAPY OF PROSTATIC ADENOCARCINOMA [J].
TORTI, FM ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :681-689
[23]  
WHITMORE WF, 1973, CANCER, V32, P1104, DOI 10.1002/1097-0142(197311)32:5<1104::AID-CNCR2820320515>3.0.CO
[24]  
2-T
[25]  
YAGODA A, 1973, CANCER-AM CANCER SOC, V32, P1131, DOI 10.1002/1097-0142(197311)32:5<1131::AID-CNCR2820320519>3.0.CO
[26]  
2-N
123